Clinical Trials Directory

Trials / Sponsors / National Cancer Center, Japan

National Cancer Center, Japan

Other Government · 14 registered clinical trials — 9 currently recruiting.

StatusTrialPhaseStarted
RecruitingEnfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-b
Advanced Small Bowel Adenocarcinoma
Phase 22025-11-04
Not Yet RecruitingA Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Freq
NSCLC, Stage I, II, III
—2025-03-01
RecruitingPembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients
Angiosarcoma of Skin, Angiosarcoma Metastatic
Phase 22024-12-01
RecruitingFirst-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carci
Untreated Advanced or Recurrent Thymic Carcinomas
Phase 22023-09-04
RecruitingBinimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Low-grade Glioma, Pancreatic Cancer
Phase 22023-03-29
RecruitingAsian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY St
HER2-positive Breast Cancer
—2022-05-24
RecruitingMarker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
Rare Malignant Neoplasm
—2021-11-30
UnknownAsian Multicenter Prospective Study of ctDNA Sequencing
Cervical Cancer, Ovarian Clear Cell Carcinoma, Nasopharyngeal Carcinoma
—2021-11-01
RecruitingNCCH2006/MK010 Trial (FORTUNE Trial)
Advanced or Recurrent Solid Tumors, FGFR Gene Alterations
Phase 22021-06-15
RecruitingA Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC
Esophageal Squamous Cell Carcinoma
Phase 32020-07-01
CompletedA Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma
Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 12019-05-07
UnknownPAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cance
Breast Neoplasms
Phase 32018-02-09
CompletedA Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer
Gastric Cancer, Gastroesophageal Junction Region (GEJ) Cancer
Phase 1 / Phase 22017-01-01
CompletedTrial of Antibiotic Prophylaxis in Elective Colorectal Surgery
Colorectal Surgery
Phase 32004-05-01